Pro Medicus's Renewals Dispelling AI-Disruption Fears -- Market Talk

Dow Jones
06/04

0454 GMT - Pro Medicus's latest contract renewal shows that customers are expanding usage rather than cutting deal lengths, RBC analyst Jackson Lee says. Some investors had worried that customers of companies including the Australian medical-imaging tech provider would try to shorten contracts to preserve the option of switching to AI-driven alternatives. However, Lee writes in a note that the A$16 million renewal with Ohio State University Wexner Medical Center was for an unchanged five years. The center is also taking up new product modules, he adds. RBC has a last-published sector perform rating and a A$195.00 target price on the stock, which is down 0.6% at A$158.74. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

June 04, 2026 00:54 ET (04:54 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10